Prenetics Sells ACT Genomics Stake for $71.78 Million to Strengthen Bitcoin Financial Strategy
Nasdaq-listed company Prenetics has announced that it has reached a definitive agreement to transfer its ownership in ACT Genomics Holdings Company Limited to Delta Electronics, Inc. for approximately $71.78 million. The divestment of ACT Genomics has significantly strengthened Prenetics’ financial position, with cash reserves expected to reach around $86 million and total cash and short-term assets projected at $117 million. The company maintains a debt-free balance sheet, enabling it to explore other financial management options, including the adoption of digital assets and Bitcoin treasury strategies. (Globenewswire)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Netflix (NFLX.US) reportedly plans to lay off about 5% of its staff: The streaming giant faces growth pressure and trims its workforce ahead of earnings report.
According to reports, Netflix plans to lay off about 5% of its employees as early as next week.
Citi: Besent May "Slash" Long-term Bond Issuance Next Month, 20-year US Treasury Issuance Could Be Directly Canceled
Citi published a research report indicating that US Treasury Secretary Scott Besant is highly likely to reduce the issuance size of long-term US Treasury bonds, and may even completely cancel the issuance of 20-year Treasury bonds.
Rising energy prices intensify inflation concerns; US Treasury yields increase again, with the 10-year rising to 5.25%.
Persistently high energy prices have intensified market concerns about the inflation outlook and reinforced investor expectations of further interest rate hikes by the Federal Reserve. After experiencing significant volatility earlier this week, U.S. Treasury yields are edging back toward recent highs.

